vs
AMERICAN PUBLIC EDUCATION INC(APEI)与Orthofix Medical Inc.(OFIX)财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是AMERICAN PUBLIC EDUCATION INC的1.4倍($219.9M vs $158.3M),AMERICAN PUBLIC EDUCATION INC净利率更高(8.0% vs -1.0%,领先9.0%),Orthofix Medical Inc.同比增速更快(2.0% vs -3.5%),Orthofix Medical Inc.自由现金流更多($16.8M vs $-15.6M),过去两年Orthofix Medical Inc.的营收复合增速更高(8.0% vs 1.3%)
美国公共教育公司(股票代码APEI)旗下控股教育服务企业Strategic Education Inc,运营着卡佩拉大学、斯特雷耶大学两所营利性在线大学,还拥有DevMountain、Hackbright Academy、Sophia Learning等非学历教育项目,主营面向在职人群的成人教育服务。
Orthofix医疗是全球知名骨科医疗器械企业,专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品,服务全球多地的骨科医师与医疗机构,致力于提升肌肉骨骼疾病患者的诊疗效果。
APEI vs OFIX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $158.3M | $219.9M |
| 净利润 | $12.6M | $-2.2M |
| 毛利率 | 56.4% | 71.1% |
| 营业利润率 | 12.0% | 0.2% |
| 净利率 | 8.0% | -1.0% |
| 营收同比 | -3.5% | 2.0% |
| 净利润同比 | -2.7% | 92.4% |
| 每股收益(稀释后) | $0.67 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $158.3M | $219.9M | ||
| Q3 25 | $163.2M | $205.6M | ||
| Q2 25 | $162.8M | $203.1M | ||
| Q1 25 | $164.6M | $193.6M | ||
| Q4 24 | $164.1M | $215.7M | ||
| Q3 24 | $153.1M | $196.6M | ||
| Q2 24 | $152.9M | $198.6M | ||
| Q1 24 | $154.4M | $188.6M |
| Q4 25 | $12.6M | $-2.2M | ||
| Q3 25 | $5.6M | $-22.8M | ||
| Q2 25 | $4.5M | $-14.1M | ||
| Q1 25 | $8.9M | $-53.1M | ||
| Q4 24 | $13.0M | $-29.1M | ||
| Q3 24 | $2.3M | $-27.4M | ||
| Q2 24 | $371.0K | $-33.4M | ||
| Q1 24 | $516.0K | $-36.0M |
| Q4 25 | 56.4% | 71.1% | ||
| Q3 25 | 54.2% | 72.2% | ||
| Q2 25 | 51.8% | 68.7% | ||
| Q1 25 | 54.5% | 62.8% | ||
| Q4 24 | 56.3% | 69.0% | ||
| Q3 24 | 50.8% | 68.7% | ||
| Q2 24 | 50.2% | 67.8% | ||
| Q1 24 | 53.1% | 67.5% |
| Q4 25 | 12.0% | 0.2% | ||
| Q3 25 | 5.9% | -8.3% | ||
| Q2 25 | 4.3% | -7.9% | ||
| Q1 25 | 7.4% | -25.2% | ||
| Q4 24 | 13.1% | -5.3% | ||
| Q3 24 | 2.7% | -9.6% | ||
| Q2 24 | 1.5% | -12.5% | ||
| Q1 24 | 3.4% | -15.6% |
| Q4 25 | 8.0% | -1.0% | ||
| Q3 25 | 3.4% | -11.1% | ||
| Q2 25 | 2.8% | -6.9% | ||
| Q1 25 | 5.4% | -27.4% | ||
| Q4 24 | 7.9% | -13.5% | ||
| Q3 24 | 1.5% | -13.9% | ||
| Q2 24 | 0.2% | -16.8% | ||
| Q1 24 | 0.3% | -19.1% |
| Q4 25 | $0.67 | $-0.05 | ||
| Q3 25 | $0.30 | $-0.57 | ||
| Q2 25 | $-0.02 | $-0.36 | ||
| Q1 25 | $0.41 | $-1.35 | ||
| Q4 24 | $0.63 | $-0.76 | ||
| Q3 24 | $0.04 | $-0.71 | ||
| Q2 24 | $-0.06 | $-0.88 | ||
| Q1 24 | $-0.06 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $174.1M | $82.0M |
| 总债务越低越好 | $94.7M | — |
| 股东权益账面价值 | $294.8M | $450.0M |
| 总资产 | $521.4M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势,按日历期对齐
| Q4 25 | $174.1M | $82.0M | ||
| Q3 25 | $191.3M | $62.9M | ||
| Q2 25 | $174.9M | $65.6M | ||
| Q1 25 | $161.6M | $58.0M | ||
| Q4 24 | $131.9M | $83.2M | ||
| Q3 24 | $135.4M | $30.1M | ||
| Q2 24 | $129.8M | $26.4M | ||
| Q1 24 | $125.3M | $27.0M |
| Q4 25 | $94.7M | — | ||
| Q3 25 | $94.4M | $157.2M | ||
| Q2 25 | $94.1M | $157.0M | ||
| Q1 25 | $93.7M | $156.9M | ||
| Q4 24 | $93.4M | $157.0M | ||
| Q3 24 | $93.1M | $118.5M | ||
| Q2 24 | $92.8M | $118.0M | ||
| Q1 24 | $95.0M | $118.2M |
| Q4 25 | $294.8M | $450.0M | ||
| Q3 25 | $279.3M | $442.5M | ||
| Q2 25 | $272.2M | $458.3M | ||
| Q1 25 | $310.0M | $458.3M | ||
| Q4 24 | $303.9M | $503.1M | ||
| Q3 24 | $290.4M | $525.9M | ||
| Q2 24 | $288.7M | $546.0M | ||
| Q1 24 | $288.5M | $570.3M |
| Q4 25 | $521.4M | $850.6M | ||
| Q3 25 | $525.3M | $832.6M | ||
| Q2 25 | $537.4M | $837.2M | ||
| Q1 25 | $578.7M | $823.1M | ||
| Q4 24 | $570.1M | $893.3M | ||
| Q3 24 | $569.6M | $867.9M | ||
| Q2 24 | $560.7M | $882.0M | ||
| Q1 24 | $559.0M | $906.0M |
| Q4 25 | 0.32× | — | ||
| Q3 25 | 0.34× | 0.36× | ||
| Q2 25 | 0.35× | 0.34× | ||
| Q1 25 | 0.30× | 0.34× | ||
| Q4 24 | 0.31× | 0.31× | ||
| Q3 24 | 0.32× | 0.23× | ||
| Q2 24 | 0.32× | 0.22× | ||
| Q1 24 | 0.33× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-11.6M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.6M | $16.8M |
| 自由现金流率自由现金流/营收 | -9.9% | 7.6% |
| 资本支出强度资本支出/营收 | 2.6% | 4.9% |
| 现金转化率经营现金流/净利润 | -0.92× | — |
| 过去12个月自由现金流最近4个季度 | $46.1M | $-1.3M |
8季度趋势,按日历期对齐
| Q4 25 | $-11.6M | $27.7M | ||
| Q3 25 | $21.7M | $12.4M | ||
| Q2 25 | $14.8M | $11.6M | ||
| Q1 25 | $37.0M | $-18.4M | ||
| Q4 24 | $1.6M | $23.7M | ||
| Q3 24 | $14.1M | $11.7M | ||
| Q2 24 | $12.5M | $9.0M | ||
| Q1 24 | $20.7M | $-18.6M |
| Q4 25 | $-15.6M | $16.8M | ||
| Q3 25 | $17.5M | $2.5M | ||
| Q2 25 | $11.1M | $4.5M | ||
| Q1 25 | $33.1M | $-25.1M | ||
| Q4 24 | $-1.8M | $15.2M | ||
| Q3 24 | $7.8M | $6.3M | ||
| Q2 24 | $7.3M | $-360.0K | ||
| Q1 24 | $14.5M | $-29.1M |
| Q4 25 | -9.9% | 7.6% | ||
| Q3 25 | 10.7% | 1.2% | ||
| Q2 25 | 6.8% | 2.2% | ||
| Q1 25 | 20.1% | -13.0% | ||
| Q4 24 | -1.1% | 7.0% | ||
| Q3 24 | 5.1% | 3.2% | ||
| Q2 24 | 4.7% | -0.2% | ||
| Q1 24 | 9.4% | -15.4% |
| Q4 25 | 2.6% | 4.9% | ||
| Q3 25 | 2.6% | 4.8% | ||
| Q2 25 | 2.3% | 3.5% | ||
| Q1 25 | 2.4% | 3.5% | ||
| Q4 24 | 2.0% | 4.0% | ||
| Q3 24 | 4.1% | 2.7% | ||
| Q2 24 | 3.4% | 4.7% | ||
| Q1 24 | 4.0% | 5.6% |
| Q4 25 | -0.92× | — | ||
| Q3 25 | 3.90× | — | ||
| Q2 25 | 3.29× | — | ||
| Q1 25 | 4.16× | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 6.22× | — | ||
| Q2 24 | 33.57× | — | ||
| Q1 24 | 40.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APEI
| American Public Education Inc Segment | $71.0M | 45% |
| Rasmussen University Segment | $66.6M | 42% |
| Hondros College Of Nursing Segment | $20.7M | 13% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |